Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | ACACB | O00763 | 5/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | SPR | P35270 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20116941 | 0.86 | CYP11B2 (0.43) | CYP11B2ACACBLRRK2HSD17B10CYP3A4 | |
| SCHEMBL27390807 | 0.76 | CYP3A4 (0.56) | CYP11B2HSD17B10CYP3A4USP2CYP2C19 | |
| SCHEMBL22581814 | 0.76 | CDK8 (0.55) | LRRK2CYP2C19ALDH1A1RETMAPT | |
| SCHEMBL30990863 | 0.75 | HDAC2 (0.44) | CYP11B2ACACBHSD17B10CYP3A4USP2 | |
| SCHEMBL22805048 | 0.75 | CYP3A4 (0.55) | CYP11B2HSD17B10CYP3A4USP2CYP2C19 | |
| SCHEMBL12004996 | 0.75 | CYP3A4 (0.55) | CYP11B2HSD17B10CYP3A4USP2CYP2C19 | |
| SCHEMBL30664043 | 0.75 | CYP3A4 (0.47) | CYP11B2ACACBHSD17B10CYP3A4USP2 | |
| SCHEMBL31161269 | 0.75 | CYP3A4 (0.47) | CYP11B2ACACBHSD17B10CYP3A4USP2 | |
| SCHEMBL18291310 | 0.75 | CYP3A4 (0.47) | CYP11B2ACACBHSD17B10CYP3A4USP2 | |
| SCHEMBL24793976 | 0.75 | HDAC2 (0.52) | CYP11B2ACACBHSD17B10CYP3A4USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262828-A1 | COMPOUNDS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262828-A1 | COMPOUNDS AND USES THEREOF | NLN, ACHE, CLN6 | CYP11B2 93/4885ACACB 920/4885LRRK2 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.